- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01033604
Glyaderm + Split Thickness Skin Graft Versus Split Thickness Skin Graft Alone in Full Thickness Skin Defects
Clinical Application of a Novel Dermal Substitute Based on Glycerol Preserved Allograft: GLYADERM
The application of Glyaderm for skin restoration intends to provide a more stable wound closure with enhanced pliability and function of the skin and a more favourable scar. The dermal substitute would be affordable for widespread application in full thickness skin defects and burns.
Patients with burn wounds or large full thickness wounds will be evaluated before enrollment. All burn wounds that are not clearly full thickness on clinical assessment will be treated during the first 48 hours with a hydrocolloid paste and covered with a paraffin gauze dressing. This hydrocolloid paste combined with paraffin gauze will ensure maintenance of a moist wound environment for the first 48 hours prior to assessment by LDI and randomization. This is the standard treatment for all burns admitted to the Ghent Burn Centre.
Wounds will be photographed on a daily basis. In order to obtain an optimal preparation for LDI, the burn wounds will be meticulously debrided during dressing changes. LDI is most reliable between 48-72 hours. Patients whose burn wounds meet the inclusion criteria, i.e. full thickness burns with LDI values < 200 will be randomized to receive either GLYADERM and split skin graft versus split skin graft alone.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ghent, Belgium, 9000
- University Hospital Ghent
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All burn wounds with flux values measured by Laser Doppler Imaging, corresponding with an expected healing time longer than 28 days. Dark blue color on the palette of the LDI software with flux values below 200
- All clearly full thickness burns on clinical assessment done by two plastic surgeons and thereafter treated with Flammacerium®.
- Wounds treated with a hydrocolloid paste prior to LDI and with low flux values < 200
- All assessments are done during first days before final decision at day three
- Possibility to follow the complete treatment schedule until final graft take and subsequently wound healing and finally participation on complete follow-up schedule
- Informed consent has been obtained
- TBSA Full Thickness Burn < 40%
Exclusion Criteria:
- All burn wounds with flux values measured by Laser Doppler Imaging, corresponding with faster healing times ( flux values >200 )
- TBSA >40 %
- Not following the complete treatment schedule or missing some evaluations during the follow-up period
- Patient has any condition(s) that seriously compromises the patient's ability to complete this study.
- Patient has participated in another study utilizing an investigational drug within the previous 30 days
- Patient has one or more medical condition(s), diabetes, including renal, hepatic, hematologic, neurologic, or immune disease that in the opinion of the investigator would make the patient an inappropriate candidate for this study
- Patients wish to decline from the study
- No informed consent before start of the trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Glyaderm and split skin graft
Full thickness defects treated with Glyaderm and split skin graft.
|
Full thickness defects treated with Glyaderm and split skin graft.
|
|
Active Comparator: Split skin graft alone
Full thickness defects treated with split skin graft alone.
|
Full thickness defects treated with split skin graft alone.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Comparison of healing time and percentage of autograft survival
Time Frame: After one week
|
After one week
|
|
Comparison in bacterial control in full thickness defects
Time Frame: On day 3,5 an 7 post application of Glyaderm
|
On day 3,5 an 7 post application of Glyaderm
|
|
To assess the monitoring of dermal substitute ingrowth with Laser Doppler Imaging
Time Frame: On day 3, 5 and 7 post application of Glyaderm
|
On day 3, 5 and 7 post application of Glyaderm
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To evaluate the functional and cosmetic outcome of skin restoration of full thickness defects treated with Glyaderm and split skin graft versus split skin graft alone
Time Frame: 1 month, 3, 6 and 12 months post wound closure
|
1 month, 3, 6 and 12 months post wound closure
|
|
Cost-effectiveness and Health related quality of life (i.e. cost utility analysis)
Time Frame: 1 month, 3, 6 and 12 months post wound closure
|
1 month, 3, 6 and 12 months post wound closure
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2007/033
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Full Thickness Skin Defects
-
University Children's Hospital, ZurichUniversity of Zurich; Swiss National Science Foundation; Centre Hospitalier Universitaire...Not yet recruitingFull Thickness Skin Defects | Burn Degree Second | Burn Degree Third | Skin TransplantationSwitzerland
-
Association of Dutch Burn CentresSeventh Framework Programme; Ernst Reichmann Tissue Biology Research Unit,...CompletedFull Thickness Skin DefectsNetherlands, Germany
-
Association of Dutch Burn CentresSeventh Framework Programme; Ernst Reichmann Tissue Biology Research Unit,...CompletedFull Thickness Skin DefectsNetherlands, Germany, Switzerland
-
Pontificia Universidad Catolica de ChileHospital del Trabajador de Santiago; SymbiOx Inc.RecruitingCronic Full-thinkness Skin Wound | Acute Full-thickness Skin WoundChile
-
Adichunchanagiri Institute of Medical Sciences,...CompletedUlcer | Full Thickness Skin DefectsIndia
-
Assiut UniversityUnknownBurn With Full-Thickness Skin Loss
-
First Hospital of China Medical UniversityCompletedGastric Submucosal Tumors | Endoscopic Full Thickness Resection (EFTR)China
-
Smith & Nephew, Inc.CompletedPartial Thickness Supraspinatus Tendon Tear | Full Thickness Supraspinatus Tendon TearUnited States
-
Brigham and Women's HospitalTerminatedSurgical Wound | Wound Heal | Wound of Skin | Full Thickness Skin Graft HealingUnited States
-
Amarantus BioScience Holdings, Inc.Amarex Clinical ResearchUnknownThermal Injury | Deep Partial-Thickness Burn | Full-Thickness BurnUnited States
Clinical Trials on Glyaderm and split skin graft
-
University Hospital, GhentResearch Foundation FlandersCompletedBurns | Necrotizing Fascitis | Full Thickness BurnBelgium
-
Markman Biologics CorporationUnknown
-
Indonesia UniversityRecruitingBurn Degree Second | Burn Degree ThirdIndonesia
-
Euro Tissue BankDutch Burns FoundationTerminatedFull-thickness Skin Loss Due to Burn, Unspecified SiteSpain, Netherlands, Belgium, Greece
-
Avita MedicalUnited States Department of Defense; Royal Perth Hospital; MedDRA Assistance Inc and other collaboratorsCompleted
-
Association of Dutch Burn CentresCompletedBurns | ScarsNetherlands
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruiting
-
Coordinación de Investigación en Salud, MexicoUnknownBurns | Skin UlcerMexico
-
Assiut UniversityWithdrawn
-
CUTISS AGUniversity of Zurich; University Hospital, Zürich; Julius Clinical; Sintesi Research... and other collaboratorsActive, not recruitingBurnsSwitzerland, Italy, Netherlands